str-p004
Cell therapyexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 30, 2025 (NCT07003178)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- B-lymphocyte antigen CD19Immunity, passive
CD19 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07245251 | N/A | Dec 3, 2025 | Starna Therapeutics |
| NCT07143617 | N/A | Sep 15, 2025 | Government of China, Starna Therapeutics |
| NCT07003178 | Early Phase 1 (Phase 1) | Jun 30, 2025 | Starna Therapeutics |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Starna Therapeutics | For profit | 3 | 2 | 2 | 2025 |
| Government of China | Government | 1 | 1 | 1 | 2025 |
2 organizations
Page 1 / 1